Jiangsu Nhwa Pharmaceutical Co. Ltd. (002262)

Overview

Jiangsu Nhwa Pharmaceutical Co., LTD is a prominent pharmaceutical company that specializes in the research and development, production, marketing, and services of central nervous system drugs. With a focus on both the Chinese market and international presence, the company has been serving the healthcare industry since its establishment in 1978. Headquartered in Xuzhou, China, Jiangsu Nhwa Pharmaceutical prides itself on its significant contributions to the areas of anesthesia, analgesia, and treatments for mental, neurological, and psychiatric disorders. The company boasts a wide distribution network that spans hospitals, private hospitals, online pharmacies, and chain pharmacies, ensuring their products are accessible to a broad audience worldwide.

Products and Services

• Anesthesia and Analgesia

  These products are designed to support surgical procedures by providing sedation and pain relief. Jiangsu Nhwa Pharmaceutical develops anesthetics and analgesic drugs that cater to various surgical and medical needs, ensuring patient comfort and procedural efficiency.

• Mental and Neurological Disease Treatments

  The company offers a variety of pharmaceuticals aimed at managing and treating mental health conditions and neurological disorders. Their portfolio includes medications that address a range of issues, from depression and anxiety to more complex neurological diseases, underlining their commitment to improving mental health and quality of life for patients.

• Narcotic Drugs

  Jiangsu Nhwa Pharmaceutical produces a line of narcotic drugs that are strictly regulated and used for specific medical purposes. These drugs are typically employed to manage severe pain and are available through controlled distribution channels to ensure safe and effective use.

• Psychiatry and Neurological Medications

  The company's psychiatric and neurological drugs further demonstrate its expertise in central nervous system treatments. These medications are essential for the treatment and management of psychiatric disorders and neurological conditions, contributing to the wide range of therapeutic solutions Jiangsu Nhwa Pharmaceutical provides.

• Active Pharmaceutical Ingredients (APIs)

  Aside from finished pharmaceutical products, Jiangsu Nhwa Pharmaceutical also supplies Active Pharmaceutical Ingredients (APIs), which are critical for the manufacture of various drugs. These APIs are produced under stringent quality control standards to ensure efficacy and safety for downstream pharmaceutical production and, ultimately, patient care.